Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Adams CM 

PROVIDER: S-EPMC7056566 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature